To explore the postmortem physiological mechanism of muscle, activity of adenosine 19 monophosphate activated protein kinase (AMPK) as well as its role in energy 20 metabolism of postmortem yaks were studied. In this experiment, we injected 5-amino-21 1-beta-d-furanonyl imidazole-4-formamide (AICAR), a specific activator of AMPK, 22 and the specific AMPK inhibitor STO-609, to observe the changes in glycolysis, energy 23 metabolism, AMPK activity and AMPK gene expression (PRKA1 and PRKA2) in 24 postmortem yaks during maturation. The results showed that AICAR could increase the 25 expression of the PRKKA1 and PRKAA2 genes, activate AMPK and increase its 26 activity. The effects of AICAR include a lower concentration of ATP, an increase in 27 AMP production, an acceleration of glycolysis, an increase in the lactic acid 28 concentration, and a decrease in the pH value. In contrast, STO-609 had the opposite 29 effect. Under hypoxic adaptation, the activity of the meat AMPK increased, which 30 accelerated glycolysis and metabolism, and more effectively regulated energy 31 production. 32 Keywords: AICAR; STO-609; AMP-activated protein kinase; yak; energy metabolism; 33 skeletal muscle. 34 1. Introduction 35 Yaks adapted to high altitudes because of the colder climate. This process included 36 the maintenance of the production of adenosine triphosphate (ATP) through an increase 37 in glycolysis. Studies have shown that yaks have specific metabolic mechanisms that 38 enable them to adapt to a hypoxic environment to attain an adequate supply of energy 39 and a demand balance under hypoxic conditions. (Zuo et al., 2017; Hardie, Ross, 40 Hawley, 2012; Hardie, 2003). AMP-activated protein kinase (AMPK), as an important 41 cellular energy sensor, is critical for the regulation of the metabolism of energy and the 3 42 subsequent quality of the meat. Under hypoxic conditions, the body is under stress; 43 metabolism is strengthened; ATP consumption is increased; the ATP concentration is 44 decreased; the AMP production is increased, and a high concentration of 5'-AMP and 45 AMPK gamma subunits interact to activate AMPK. Ding et al. (2014) studied the 46 activity of lactate dehydrogenase (LDH) in yaks at three different altitudes, and its 47 activity positively correlated with altitude. LDH is the key enzyme for anaerobic 48 glycolysis, indicating that yaks at higher altitudes are more dependent on energy 49 metabolism (Chen, 2003; Wojtaszewski, 2000; Musi, 2001; Park, 2002) 50 Under hypoxic conditions, the body is under stress; metabolism is strengthened; 51 ATP consumption is increased; the ATP concentration is decreased; AMP production 52 is increased, and a high concentration of 5'-AMP and AMPK gamma subunits interact 53 to activate AMPK (Park et al., 2002). Research on the activity of lactate dehydrogenase 54 (LDH) in yaks at three different altitudes indicated that the enzyme is positively 55 correlated with altitude. LDH is the key enzyme for anaerobic glycolysis, indicating 56 that yaks at higher altitudes are more dependent on the metabolism of energy (Ding et 57 al., 2014). Thus, it is necessarily to additionally study changes of energy metabolism 58 and AMPK activity in a hypoxic environment. 59 The enzyme AMPK is a heterotrimer consisting of α, β, and γ subunits. Its primary 60 role is thought to be the critical regulation of energy metabolism (Hardie, 2004; Carling, 61 2004; Winder, 2001; Hardie & Carling, 1997). AMP/ATP ratio increase in muscle cells 62 is thought to result in the activation of AMPK. This activation results in the 63 phosphorylation of AMPK at Thr172 by a kinase that remains unidentified. Following 64 its activation, AMPK activates glycogenolysis/glycolysis and consuming/catabolic 65 pathways that generate ATP Any type of cellular stress can cause AMPK activation. Physiological AMP/ADP 68 elevation occurs as a result of stress, such as low nutrients or prolonged exercise. As 69 previous studies have found, the initiation of glycolysis in ischemic heart AMPK 70 activation plays an important role (Sambandam & Lopaschuk, 2003). Thus, the data 71 accumulated confirms that hypoxia is a characteristic of post-mortem skeletal muscle 72 and ischemic heart disease. Therefore, post-mortem glycolysis may be regulated by 73 AMPK. 74 Previous research demonstrated the activation of AMPK in pork loins, which 75 develop into PSE meat. This finding suggests that a key role of AMPK in regulation of 76 postmortem glycolysis (Shen, Means, Underwood, et al., 2006). Therefore, the role of 77 AMPK may be the regulation of glycolysis in post-mortem skeletal muscle. If so, the 78 enzyme may be a logical target to manipulate to intervene in the process of PSE 79 development and cause its reduction, since AMPK activity depends on the postmortem 80 skeletal muscle pH values. Therefore, we further studied AMPK role in muscle 81 glycolysis regulation in post-mortem meat, using specific AMPK activators and 82 inhibitors to detect whether the induction of AMPK by 5-amino-1-β-D-ribofuranosyl-83 imidazole-4-carboxamide (AICAR) and STO-609 affect post-mortem muscle 84 glycolysis. Recent research in rat skeletal muscle used a cell-permeable compound 85
AMPK activity measurements were based on AMPK specific phosphorylation of 143 a SAMS peptide (Shen et al., 2006) . Briefly, SAMS peptide substrate (His-Met-Arg- 144 Ser-Ala-Met-Ser-Gly-Leu-His-Leu-Val-Lys-Arg-Arg, obtained from Invitrogen, USA) 145 was used for the assay. As-obtained muscle homogenate was centrifuged at 13000g at 146 4 °C for 5 min. 10 µL of supernatant was incubated for 10 min at 37 °C at pH 7.0. Its AMPK was analyzed using the frozen yak LL muscle derived from these methods 158 as previously described (Shen et al. 2005) . Briefly, 0.05 g of muscle was homogenized 159 at top speed for 10 s on ice using a Polytron homogenizer (IKA Works, Inc., 160 Wilmington, NC). Five hundred milliliters of precooled buffer was used to homogenize 161 the tissue. The buffer contained 20 mM of Tris-HCl with pH value equal to 7.4 and at 162 initial temperature equal to 4 °C as well as 2% SDS, 5 mM EGTA, 5 mM EDTA, 1 mM 163 DTT, 100 mM NaF, 2 mM sodium vanadate, 10 mg/ml pepstatin, 0.5 mM 164 phenylmethylsulfonyl fluoride (PMSF) and 10 mg/ml leupeptin (Veiseth, Shackelford, 165 Wheeler, & Koohmaraie, 2001; Raser, Posner, & Wang, 1995) . Each of the muscle 166 homogenate was mixed with an equal volume of 2x SDS-PAGE loading buffer 8 167 containing 0.5 M TrisHCl (pH 6.8), 2% (v/v) 2-mercaptoethanol, 20 vol% glycerol, 4.4%
168
(w/v) SDS, and 0.01% bromophenol blue (boiled for 5 min prior to electrophoresis). 169 The gels were cast using a BioRad mini-gel system (Richmond, CA, USA) that 170 was also used to perform the SDS-PAGE electrophoresis. However, at 12 h postmortem and through the remaining sampling times, the muscle 218 pH of the control yak was higher (P < 0.05) than that of the AICAR-treated yak but 219 lower than STO-609-treated yak. At 24 h postmortem, the pH of the AICAR-injected 220 yak muscle remained less than 6.0, showing that the glycolytic rate was strongly 221 activated ( Fig. 1) . and suggested that this process may be mediated by a novel glucose transporter. The nucleotide concentration in the yak LL muscle was measured in this study.
239
After the 0 h control, there were no significant differences the in nucleotide 240 concentration observed between the control and treatment groups (Table 2) . However,
241
AICAR injection increased the ATP levels of the skeletal muscle, while decreasing the 11 242 concentrations of AMP and IMP (P < 0.05). This result could be due to the inhibition 243 of glycolysis in the LL muscle by the AICAR injection (Table 2 ). The AICAR injection 244 inhibited glycolysis in the postmortem muscle (Figures 2, 3) . As a result of this 245 inhibition, less ATP was produced, and the ATP concentration increased within 12 246 hours following death ( Table 2 ). The IMP in the muscles of the yaks was also 247 significantly higher than the AMP following the slaughter of the animals, and these 248 results are consistent with those of previous studies (Shen et al., 2007; Shen et al., 2006) .
249
This result reiterated an observation that postmortem skeletal muscle delamination 250 results in the rapid conversion of AMP to IMP. At the 0 h control, the nucleotide 251 concentrations between the three groups did not differ significantly (Table 2) (Table 2 ). In addition, the data showed that the levels of IMP AMPK phosphorylation was reduced following the injection of STO-609 ( Figure 5 ).
283
The activities of AMPK were higher in the skeletal muscle after death following STO- be due to the mediation of a novel glucose transporter. In total, these results provide 318 confirmation that STO-609 acts as a potent AMPK inhibitor and causes a reduction of 319 AMPK activity in postmortem yak muscles. (Figures 1, 2) . In 
364
Previous reports demonstrated that preslaughter stress quickened depletion of 365 muscle ATP levels. This reduction in the status of energy therefore results in the early 366 and rapid activation of AMPK in early postmortem stages, which makes it more likely 16 367 that pork loin will develop into PSE meat (Shen et al. 2007; Shen et al., 2006) . Primary
368
AMPK function is regulation of the internal cellular energy balance (Hardie et al., 2003; 369 Hardie et al., 1999; Winder & Hardie, 1999) . ATP depletion results in the activation of 370 AMPK, or to be more precise, an AMP/ATP ration increase (Corton et al., 1994; 371 Birnbaum, 2005; Witters et al., 2006) . AMPK is affected by the binding of AMP 372 occurring at low intracellular energy levels and high concentrations of AMP. AMPK 373 changes its conformation and becomes a more effective substrate for LKB1, which is 374 also known as upstream AMPK kinase (Hawley et al., 1995) . Additionally, LKB1 375 activates AMPK by phosphorylating it (Woods et al., 2003; Shaw et al., 2004; 376 WoodsHawley et al., 2003) . Activation of AMPK results in the switching on of fatty 377 acid oxidation and glycolysis, which results in the production of greater amounts of 378 ATP inside the cells (Carling et al., 1987; Marsin et al., 2002; Carlson & Kim, 1973) .
379
Earlier research demonstrated that the halothane gene and the stress of the pre-slaughter 380 process accelerated the depletion of muscle ATP levels. The reduction in the cellular 381 energy status during the early postmortem state subsequently leads to the earlier and 382 quicker activation of AMPK, which increases the risk of the development of PSE in 383 pork loin (Shen et al., 2007; Shen et al., 2006) .
384
Since STO-609 injections in murine LL muscle tissue result in decreased 385 glycolysis, they have implications for the regulation of AMPK in this type of tissue.
386
The results of these experiments in postmortem skeletal muscle suggest the partial phosphorylase, which is an enzyme controlling glycogenolysis and catalyzing 393 glycolysis substrate production (Russell et al., 1999; Young et al., 1997; Fraser et al., 394 1999; ) . In addition, activated AMPK is responsible for the phosphorylation and 395 activation of phosphofructokinase-2 (PFK-2) (Marsin et al., 2000) . In turn, activated 396 PFK-2 catalyzes fructose-2,6-phosphate production. PRK-1 is the most important 397 enzyme at controlling the rate of glycolysis, and the enzyme is activated allosterically 398 by fructose-2,6-phosphate.
399
In humans and mice, AICAR is commonly used as an AMPK activator; its role in 400 AMPK activation in LL muscle was established by McFadden and Corl (2009) . This also with the findings of previous research (Shen & Du, 2005a; Du et al., 2005) . In 411 concert, these findings confirm that STO-609 is a potent inhibitor of AMPK, which 412 leads to lower levels of activity of AMPK in the postmortem skeletal yak muscle. 413 We implemented real-time RT-PCR to examine AMPK mRNA expression However, this study did not enable us to identify the transcription factors that were 434 responsible for regulation increase in the gene expression of AMPK induced by AICAR.
435
Therefore, addition research to identify the transcription factors and cis-elements that 436 are involved in the response to AICAR is merited. to AICAR activation and STO-609 inhibition. This suggests that the increased 443 expression of the PRKAA1 and PRKAA2 genes will increase the activity of AMPK. 
